A patient with cystic fibrosis uses inhaled tobramycin (TOBI) 300 ...

[rayancarla1]

A patient with cystic fibrosis uses inhaled tobramycin (TOBI) 300 mg every 12 hours in repeating cycles of 4 weeks on and 4 weeks off. The patient reports hoarseness and tinnitus. The nurse will tell the patient that:
 
  a. an intravenous form may be used to avoid hoarseness.
  b. hearing loss may occur with continued use of the drug.
  c. the provider will need to monitor renal function closely.
  d. these are common side effects of this medication.

Question 2

A pregnant patient begins active labor at 30 weeks' gestation. The provider orders dexamethasone 6 mg intramuscularly to be given twice daily for 4 doses. The patient asks the nurse what effect this drug will have on the fetus.
 
  The nurse will tell her that the dexamethasone is given to:
  a. improve cognitive function in the fetus.
  b. improve fetal neuromotor development.
  c. increase fetal weight and length.
  d. increase lung development in the fetus.

[tandmlomax84]

Answer to Question 1

ANS: D
Inhaled tobramycin can cause tinnitus, but does not cause hearing loss. Hoarseness is a common side effect. An intravenous aminoglycoside can cause hearing loss and is not used chronically for cystic fibrosis. Hearing loss will not occur with inhaled tobramycin. Inhaled tobramycin does not increase the risk of renal toxicity.

Answer to Question 2

ANS: D
When preterm delivery cannot be prevented, injecting the pregnant patient with glucocorticoids can accelerate fetal lung maturation. Glucocorticoids do not improve cognitive function, neuromotor development, or physical size in the fetus.

[rayancarla1]

Gracias!

[deja]

Thanks for the timely response, appreciate it